M Tajima Selected Research

M Tajima Research Topics

Disease

3	Neoplasms (Cancer) 07/2003 - 11/2000
3	Disease Progression 07/2003 - 05/2001
2	Diarrhea 12/2006 - 07/2001
1	Alopecia (Baldness) 12/2015
1	Atopic Dermatitis (Atopic Eczema) 04/2010
1	Infections 12/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2003
1	Lupus Nephritis 03/2003
1	Acute-Phase Reaction 06/2001
1	Mastitis 06/2001
1	Urinary Tract Infections (Urinary Tract Infection) 05/2001
1	Urologic Neoplasms (Urological Cancer) 05/2001
1	Allergic Contact Dermatitis 03/2001
1	Rheumatoid Arthritis 01/2001
1	Rheumatoid Vasculitis 01/2001
1	Vasculitis (Vasculitides) 01/2001
1	Asthma (Bronchial Asthma) 01/2001
1	Carcinoma (Carcinomatosis) 11/2000
1	Hemolysis 11/2000
1	Esophageal Neoplasms (Esophageal Cancer) 10/2000
1	Bone Resorption 07/2000
1	Atrophy 05/2000
1	Exostoses 04/2000
1	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 04/2000
1	Osteoporosis 03/2000
1	Respiratory Insufficiency (Respiratory Failure) 02/2000
1	Aortic Valve Stenosis (Aortic Stenosis) 02/2000
1	Hypertrophy 02/2000
1	Cardiomegaly (Heart Hypertrophy) 02/2000
1	Hypertension (High Blood Pressure) 02/2000
1	Hypoxia (Hypoxemia) 02/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2006 - 03/2000
2	Monoclonal AntibodiesIBA 12/2006 - 03/2000
2	Tumor Biomarkers (Tumor Markers)IBA 07/2003 - 05/2001
2	2-benzyl-3-formylpropanoic acid (BFP)IBA 07/2003 - 05/2001
2	Immunoglobulin G (IgG)IBA 03/2003 - 01/2001
1	Adenosine (Adenocard)FDA LinkGeneric 12/2015
1	Immunoglobulin E (IgE)IBA 04/2010
1	IgE Receptors (Fc epsilon RI)IBA 04/2010
1	AntigensIBA 12/2006
1	nuclear matrix protein 22IBA 07/2003
1	AntibodiesIBA 03/2003
1	Glycoproteins (Glycoprotein)IBA 07/2001
1	CytokinesIBA 06/2001
1	Interleukin-1 (Interleukin 1)IBA 06/2001
1	Fetal Proteins (Fetoprotein)IBA 05/2001
1	PolyaminesIBA 05/2001
1	Indicators and Reagents (Reagents)IBA 05/2001
1	Betamethasone Valerate (Betamethasone 17 Valerate)FDA LinkGeneric 03/2001
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2001
1	AllergensIBA 01/2001
1	Cell Adhesion MoleculesIBA 01/2001
1	OvalbuminIBA 01/2001
1	Hematoxylin (Haematoxylon)IBA 11/2000
1	ParaffinIBA 11/2000
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2000
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2000
1	DNA (Deoxyribonucleic Acid)IBA 11/2000
1	RNA IIBA 11/2000
1	Epstein-Barr Virus Nuclear AntigensIBA 11/2000
1	Hemoglobins (Hemoglobin)IBA 11/2000
1	Cisplatin (Platino)FDA LinkGeneric 10/2000
1	Fluorouracil (Carac)FDA LinkGeneric 10/2000
1	Tartrate-Resistant Acid PhosphataseIBA 07/2000
1	Calcitonin Receptors (Calcitonin Receptor)IBA 07/2000
1	Retinaldehyde (Retinal)IBA 05/2000
1	Complementary DNA (cDNA)IBA 04/2000
1	Fusion Regulatory Protein-1IBA 03/2000
1	CalciumIBA 02/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2000
1	SteroidsIBA 02/2000
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2000

Therapy/Procedure

1	Chemoradiotherapy 10/2000
1	Drug Therapy (Chemotherapy) 10/2000
1	Therapeutics 02/2000